Ginkgo Bioworks to Become Public Company via Business Combination with Soaring Eagle Acquisition Corp

Ginkgo Bioworks Acquires Zymergen

July 25, 2022

Biotechnology

Ginkgo Bioworks (NYSE: DNA) will acquire Zymergen in an all‑stock transaction valuing Zymergen at about $300 million; Zymergen stockholders will receive 0.9179 Ginkgo shares per Zymergen share and will own ~5.25% of the combined company. The acquisition is intended to integrate Zymergen's automation, software, and data‑science capabilities and biological assets into Ginkgo's horizontal cell‑programming platform to expand capacity, capabilities, and efficiency across multiple end markets.

Ginkgo Bioworks Acquires Project Beacon COVID-19 LLC

January 19, 2022

Healthcare Services

Ginkgo Bioworks has acquired the assets and operations of Project Beacon COVID-19 LLC, a Boston-based social benefit organization that provided accessible COVID-19 testing across Massachusetts. The acquisition brings Project Beacon's partner relationships, digital platform, and personnel into Ginkgo’s Concentric by Ginkgo public health and biosecurity offering to expand COVID-19 monitoring and testing capabilities.

Ginkgo Bioworks Acquires Novogy's Microbial Engineering Platform

December 16, 2020

Biotechnology

Ginkgo Bioworks acquired the main assets of Novogy, Inc., absorbing Novogy's strain assets, IP portfolio, codebase and most of its technical team. The acquisition brings Novogy's expertise in lipid-producing oleaginous yeasts (notably Yarrowia lipolytica) into Ginkgo's cell‑programming platform to accelerate development of bio-based oils, chemicals and materials.

Ginkgo Bioworks Acquires Patch Biosciences

February 28, 2024

Biotechnology

Ginkgo Bioworks has acquired Patch Biosciences, a startup that built an AI platform for sequence design to advance genetic medicines. The acquisition will integrate Patch's machine‑learning models and validated assays into Ginkgo's platform to expand its gene therapy, cell therapy and RNA therapeutics capabilities for biopharma customers.

BigBear.ai Completes Business Combination With GigCapital4

December 7, 2021

AI & Machine Learning

BigBear.ai completed a business combination with SPAC GigCapital4 and emerged as a publicly traded company (NYSE: BBAI) on December 8, 2021, in a transaction that values the combined company at approximately $1.378 billion pro forma enterprise value. AE Industrial Partners is a lead private equity partner supporting the transaction; BigBear.ai will use the public listing and capital base to accelerate product development, commercial expansion across government and commercial markets, and potential inorganic growth.

Acorns Grow Incorporated to Go Public via SPAC Pioneer Merger (PACX) Valued at ~$2.2B

May 27, 2021

Financial Services

Acorns Grow Incorporated entered into a definitive business combination agreement with publicly traded SPAC Pioneer Merger Corp. to bring Acorns to the public markets. The transaction is expected to close in the second half of 2021, with the combined company having an expected pro forma fully-diluted equity value of approximately $2.2 billion.